Four female House Democrats sent a letter to the FDA commissioner on Thursday urging the agency to address concerns about the safety and regulation of tampons.
Loic Venance/AFP via Getty Images
hide caption
toggle caption
Loic Venance/AFP via Getty Images
Lawmakers are calling on the U.S. Food and Drug Administration to do more to address concerns about the ingredients in tampons after a study released earlier this summer found toxic metals in products from over a dozen popular brands.
Members of the Democratic Women’s Caucus called on the FDA to “review and improve the current safety standards for tampons” in a letter sent to Commissioner Dr. Robert Califf on Thursday.
“We urge the FDA to take swift action to ensure that women are safe from harmful and toxic substances in tampons,” they wrote. “We look forward to reviewing your plan to address these concerns and working with you on this issue.”
They did not specify a timeline or next steps.
The letter, a copy of which was shared with NPR, was signed by Reps. Summer Lee of Pennsylvania, Grace Meng of New York and policy task force co-chairs Kathy Manning of North Carolina and Ayanna Pressley of Massachusetts. The Democratic Women’s Caucus includes all Democratic women in the U.S. House of Representatives.
An FDA spokesperson told NPR that the agency “has received the letter and will respond directly to the Caucus.”
Safety concerns about tampons, and calls for stronger regulation, are not new. More than a dozen studies in recent years have evaluated the presence of various chemicals in widely used menstrual products, including a 2019 study that found higher concentrations of blood mercury in tampon users (which is cited in Thursday’s letter).
But they intensified in July after a first-of-its-kind study published in Environment International detected amounts of 16 heavy metals — including lead — in various tampons made by 14 common brands, which were not named.
Heavy metals have been linked to all sorts of negative health effects, from damaging the cardiovascular, nervous and endocrine systems to increasing cancer risks to harming maternal health and fetal development.
The study authors caution that more research is needed to determine to what extent the metals might “leach out of tampons” and into peoples’ bodies, and what health impacts they might have if so.
But they say more transparency is needed, too — especially considering millions of Americans spend so many hours with tampons inside their bodies. The study found that people who menstruate may use more than 7,400 tampons over their reproductive years.
“I think it’s important that we ask for clear labeling on our products so that people can make informed decisions for themselves based on their own values and health priorities,” lead author Jenni Shearston, a postdoctoral scholar at the UC Berkeley School of Public Health, told NPR in July.
“And I think it’s also important that we try to get better testing, especially of heavy metals like arsenic or lead in tampons so we can make sure everyone’s safe.”
When asked about the metals study in July, the FDA mentioned the “limitations” of the research — since it didn’t evaluate to what extent metals might be absorbed by the body — but said it would look into it.
The spokesperson told NPR on Thursday that the FDA has since commissioned an independent literature review and initiated an internal bench laboratory study to evaluate metals in tampons.
“These initiatives will enable FDA to complete a risk assessment of metals contained in tampons, based on a worst-case scenario of metal exposure,” they wrote, adding that the findings will be released publicly once they have been peer-reviewed. “The FDA will also continue monitoring these devices going forward as part of its total product lifecycle approach to medical devices.”
The FDA doesn’t currently require tampons to be tested for chemicals
The FDA says all tampons legally sold in the U.S. go through a review process before they can hit store shelves, but critics say that doesn’t go far enough.
Brandon Bell/Getty Images
hide caption
toggle caption
Brandon Bell/Getty Images
The FDA regulates and classifies tampons as medical devices, so manufacturers are not required to disclose their ingredients on the label the way that other consumer products do, as the letter points out.
The FDA’s tampon guidance from 2005 doesn’t mandate that products be tested for chemical contaminants. And it recommends — but doesn’t require — that tampons “be free of” the highly toxic compound dioxin as well as “any pesticide and herbicide residues.”
Chemicals could get into tampons in a number of ways, from raw materials like cotton being contaminated by pollutants in the soil and water to manufacturers intentionally adding them as odor control or antimicrobial agents.
Tampons must meet FDA requirements for safety and effectiveness before they can be legally sold in the U.S.
The spokesperson said that process involves toxicity testing, which consists of identifying potentially harmful substances — “such as some metals” — and assessing the risk of those substances coming out of the product and being absorbed by the body during single as well as repeated use.
“As part of the FDA’s review, manufacturers submit data including the results of testing to evaluate the safety of the materials used to make tampons and applicators (if present); tampon absorbency, strength, and integrity; and whether tampons enhance the growth of certain harmful bacteria or change normal bacteria levels in the vagina,” the agency explained in an online fact sheet.
The Center for Baby and Adult Hygiene Products (BAHP), a North American trade association, defended the safety of its members’ menstrual products in a 2022 statement in which it said all absorbent hygiene products “undergo a thorough safety assessment beyond what is required by the applicable regulatory framework.”
It said any chemicals in menstrual products are “not intentionally added by the manufacturers,” saying such “impurities” may be present in the environment or “even made by the human body.”
“Our members routinely test their products with external labs for the presence of background substances and these reports affirm our products are safe and that women can use them with confidence,” it said.
Thursday’s letter isn’t the first from members of Congress who want answers and action.
Sen. Patty Murray, D-Wa., the chair of the Senate Appropriations Committee, sent a letter to Califf of the FDA in late July, several weeks after the publication of the metals study.
“In light of this alarming reporting, I urge the U.S. Food and Drug Administration (FDA) to carefully examine these new findings and evaluate any necessary actions to ensure the safety of tampons and menstrual products,” Murray wrote.
Murray asked the FDA to respond in writing to six specific questions about what it currently does and plans to do to ensure the safety of period products, and to brief her staff on the “regulation and safety processes for tampons and menstrual products,” by specific dates in August.
NPR has reached out to Murray’s office about the status of those requests. The FDA says it “will respond directly to Senator Murray regarding questions in the letter.”
Some states are passing their own laws in the absence of federal requirements
New York was the first state to require manufacturers to disclose ingredients on the packing of period products, with a law that took effect in 2021. California and Nevada have since followed suit.
Bennett Raglin/Getty Images
hide caption
toggle caption
Bennett Raglin/Getty Images
Congress has tried unsuccessfully in the past to strengthen regulations on tampons and other menstrual products.
In 2022, Reps. Debbie Lesko, R.-Ariz., and Meng — one of the letter’s signatories — introduced the “Menstrual Products Right to Know Act,” which would have required the federal Food, Drug and Cosmetic Act to “treat menstrual products as misbranded if their labeling does not list each component of the product.”
The legislation was referred to a subcommittee and did not progress further.
In a report that same year, the House Appropriations Committee expressed concern about the “potential danger of fragrance ingredients used in menstrual products that are medical devices.
“These products are used frequently by consumers without knowledge of the presence of these ingredients, or understanding of their potential harms,” lawmakers wrote, noting that the FDA does not currently maintain a list of such ingredients.
The committee’s report directed the agency to evaluate the fragrance ingredients in its existing records and “if necessary” compile a list. It also directs the FDA to determine at what concentrations it would recommend that manufacturers disclose the presence of such ingredients in their product labels.
The FDA spokesperson said the agency will continue working to update its existing guidance to include recommendations outlined in the report, and “looks forward to engaging with patients, health care providers, and others during a public comment period when those guidance updates are proposed.”
In the meantime, some states are taking matters into their own hands.
In 2019, New York became the first to pass a law requiring manufacturers to contain a “plain and conspicuous” list of ingredients on the packaging for menstrual products. It took effect in 2021.
The nonprofit group Women’s Voices for the Earth (WVE) conducted a field study on ingredient disclosures from late 2021 to early 2022 and found that the ingredients newly announced on period product labels included chemicals that can irritate skin, trigger allergic reactions, cause cancer and release microplastic particles into the environment.
“Numerous additives to period products are now being disclosed for the first time, indicating that chemical exposure from period products is much more complicated than previously assumed,” they wrote in a May 2022 report.
The group also noted that while compliance with New York law was imperfect — for example, some products described ingredients as “fragrance” or “adhesive” without including the actual chemical names — ingredient information appeared to be becoming more standard on menstrual product labels nationwide.
“We commonly found products in other states with ingredient disclosures on the package similar or identical to what is required in New York, affording period product users across the country the right to know what is in their products,” WVE added.
California followed suit in 2020, passing a law that requires period product manufacturers to disclose “intentionally added ingredients” both on labels and online starting in 2023. And last year, Nevada became the third state to require ingredient disclosure, with a law slated to take effect at the start of 2025.
In June, Vermont became the first state to ban so-called PFAS, or “forever chemicals,” from menstrual products; that law is poised to take effect in 2026.
Half a dozen other states have also enacted phaseouts of PFAS in menstrual products so far, according to the national environmental health alliance Safer States. They include Maine, Colorado, Connecticut and Minnesota.
